We are aware of recent media reports suggesting that Mounjaro (tirzepatide), a new weight-loss medication, is now available on the NHS.
While NICE (National Institute for Health and Care Excellence) has approved Mounjaro for a specific group of patients, those aged over 18 with a BMI ≥ 40 (or ≥ 37.5 for people from Black, Asian or other minority ethnic backgrounds) and at least four weight-related health conditions such as:
- Type 2 diabetes
- Hypertension (high blood pressure)
- Dyslipidaemia (abnormal cholesterol/fat levels)
- Obstructive sleep apnoea
- Cardiovascular disease
This treatment is not yet available to prescribe in general practice in Norfolk and Waveney.
Our local Integrated Care Board (ICB) has not yet commissioned a service that allows GPs to prescribe Mounjaro. Instead, they are currently working towards commissioning a community weight management service that may provide access to such treatments in the future.
What This Means for You
- We are unable to prescribe Mounjaro at this time.
- If you have queries or wish to express interest in the availability of this treatment, you may contact Norfolk and Waveney ICB directly.
- Please do not contact the surgery to request this medication. It is not currently available to us for prescribing.
- We will continue to support our patients with weight management using the tools currently available, including lifestyle support and referrals to appropriate services.
- We will contact eligible patients directly once a clear prescribing pathway is in place.
Thank you for your understanding.